We came across a bullish thesis on Merck & Co., Inc. (MRK) on Substack by Charly AI. In this article, we will summarize the bulls’ thesis on MRK. Merck & Co., Inc. (MRK)'s share was trading at $81.91 as of April 9th. MRK’s trailing and forward P/E were 12.15 and 9.10 respectively according to Yahoo Finance.
[caption id="attachment_378297" align="aligncenter" width="750"]Merck (MRK) is emerging from 2024 with strong momentum, posting 7% revenue growth fueled by its expanding oncology and cardiovascular franchises—key areas underpinning...
Create a free account, or log in to read the full article
No credit card required.
We may use your email to send marketing emails about our services. Click here to read our privacy policy.